Stock ABZENA PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Abzena PLC Share Price

Equities

GB00BN65QN46

Biotechnology & Medical Research

Chart Abzena PLC

Dynamic Chart

Press releases Abzena PLC

Abzena : Cancellation - Abzena Plc PU
Abzena : Scheme of Arrangement becomes Effective PU
Abzena : Court sanction of the scheme of arrangement PU
Abzena : Exercise of options PU
Abzena : Form 8.5 (EPT/RI) Abzena Plc PU
More press releases

Managers and Directors - Abzena PLC

Managers TitleAgeSince
Matthew Stober CEO
 Chief Executive Officer 57 12/22/12
Louise Duffy CTO
 Chief Tech/Sci/R&D Officer - 01/21/01
Campbell Bunce CTO
 Chief Tech/Sci/R&D Officer 54 01/15/01
Members of the board TitleAgeSince
Michelle Dawn Neaves BRD
 Director/Board Member 48 21/18/21
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock